Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025, after U.S. market close.

About Standard BioTools Inc.

Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary SomaScan, mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook ^® , LinkedIn, and YouTube™.

Limited Use Label License and other terms may apply: standardbio.com/legal/salesterms .
Patent and License Information: standardbio.com/legal/notices .
©2025 Standard BioTools Inc. All rights reserved.

Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.

Investor Contact:
ir@standardbio.com

News Provided by GlobeNewswire via QuoteMedia

Standard BioTools LAB NGS:LAB biotech investing

LAB

Silver Viper Hits 11.70 M @ 9.18 G/T Au And 352.0 G/T Ag Including 0.50 M @ 183.50 G/T Au And 6,850 G/T Ag While Infill Drilling At El Rubi And Expands The 5,000 M Drill Program At La Virginia Project In Sonora Mexico

Silver Viper Minerals Corp. (TSXV: VIPR,OTC:VIPRF,OTC:VIPRF) (OTCQB: VIPRF) ("Silver Viper" or the "Company") is pleased to announce drill results from the previously announced drill program (October 2, 2025 Press Release) and highlights two anomalous exploration drill intercepts at El Molino,... Keep Reading...

NevGold Intercepts 11.42 g/t AuEq Over 7.7 Meters Within 4.91 g/t AuEq Over 27.4 Meters ; Initial Antimony-Gold Mineral Resource Estimate On Schedule For Q2-2026 With Focus On Near-Term Antimony Production

Nevgold Corp. ("NevGold" or the "Company") (TSXV:NAU,OTC:NAUFF) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce further positive oxide antimony-gold drill results at its Limousine Butte Project (the "Project", "Limo Butte") in Nevada. The Company is also pleased to announce the initial... Keep Reading...

Brixton Metals Reports Record Silver Intercepts of 18.2m of 3,638 g/t Ag Including 6.8m of 9,421 g/t Ag at its Langis Project in Ontario

Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the "Company" or "Brixton") is pleased to announce the second batch of results from its ongoing exploration at the wholly owned Langis Silver Project, located in the historic silver mining camp of Cobalt, Ontario, Canada. The past producing... Keep Reading...

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

Seegnal Inc. (TSXV: SEGN), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced its deepened partnership with Tel Aviv Sourasky Medical Center ("Sourasky Medical Center"). Israel's second-largest public hospital, Sourasky... Keep Reading...

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has closed its previously announced private... Keep Reading...

Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Brixton Metals Drills 82,334 g/t Silver Over 0.5m within 11.35m of 4,560 g/t Silver at its Langis Project

Providence Gold Mines Inc. LA DAMA de ORO GOLD Update

Silver Viper Hits 11.70 M @ 9.18 G/T Au And 352.0 G/T Ag Including 0.50 M @ 183.50 G/T Au And 6,850 G/T Ag While Infill Drilling At El Rubi And Expands The 5,000 M Drill Program At La Virginia Project In Sonora Mexico

NevGold Intercepts 11.42 g/t AuEq Over 7.7 Meters Within 4.91 g/t AuEq Over 27.4 Meters ; Initial Antimony-Gold Mineral Resource Estimate On Schedule For Q2-2026 With Focus On Near-Term Antimony Production

Brixton Metals Reports Record Silver Intercepts of 18.2m of 3,638 g/t Ag Including 6.8m of 9,421 g/t Ag at its Langis Project in Ontario

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

5 Small-cap Biotech ETFs to Watch

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Latest News

Interactive Chart

Latest Press Releases

Cerro Chacon Project - Drilling Update

American Rare Earths Ltd Commissions Oxide to Metal Study for Heavy Rare Earths

Hyterra and Ara Sign MOU for Oman Geologic Hydrogen

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

Related News

Cerro Chacon Project - Drilling Update

American Rare Earths Ltd Commissions Oxide to Metal Study for Heavy Rare Earths

Top 5 Canadian Mining Stocks This Week: Altura Energy Jumps 81 Percent

Top 5 Junior Gold Mining Stocks on the TSXV

Top 10 Tungsten-producing Countries

Hyterra and Ara Sign MOU for Oman Geologic Hydrogen

Trillion Energy Announces Debenture Settlement Agreement

TOP STOCKS